"Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making. by Dakin, H, Devlin, N, Odeyemi, I

Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence by Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF

Get full text

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales by Muduma G, Shaw J, Hart WM, Odeyemi A, Odeyemi I

Get full text

Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients by Muduma G, Shupo FC, Dam S, Hawken NA, Aballéa S, Odeyemi I, Toumi M

Get full text

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation by Wex J, Sidhu M, Odeyemi I, Abou-Setta AM, Retsa P, Tombal B

Get full text

Epidemiology, prescribing patterns and resource use associated with overactive bladder in UK primary care. by Odeyemi, I, Dakin, H, O'Donnell, R, Warner, J, Jacobs, A, Dasgupta, P

Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. by Kalsi, V, Popat, R, Apostolidis, A, Kavia, R, Odeyemi, I, Dakin, H, Warner, J, Elneil, S, Fowler, C, Dasgupta, P